Carbamazepine-induced erythema multiforme major in an epileptic patient with bipolar affective disorder
Suneet K. Upadhyaya1★, Rangeel S. Raina1, Archana Sharma1, Vijay Thawani1, Deepak Dimari1★ Corresponding author
- 1Departments of Psychiatry, Pharmacology, Obstetrics and Gynaecology, Dermatology, VCSG Govt. Medical Science and Research Institute, Srinagar Garhwal, Uttarakhand, India.
CORRESPONDENCE
Suneet K. Upadhyaya
Departments of Psychiatry, Pharmacology, Obstetrics and Gynaecology, Dermatology, VCSG Govt. Medical Science and Research Institute, Srinagar Garhwal, Uttarakhand, India.
Volume 3, Issue 2 · pp. 202–204 · PUBLISHED 2012 · DOI: 10.4103/0976-500X.95537
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Carbamazepine (CBZ) is frequently used for epilepsy and various psychiatric illnesses. It is known for its dermatological side effects which may range from mild rash to life-threatening reactions as Stevens Johnson syndrome or toxic epidermal necrolysis. We hereby report a rare case of 17-year-old woman suffering from generalized tonic clonic epilepsy with comorbid bipolar affective disorder, who was initially treated with sodium valproate with partial improvement. After 19 days of addition of CBZ to the therapy, the patient developed erythema multiforme major with >60% skin involvement and oral, conjunctival, intestinal, and vaginal mucosal involvement.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Upadhyaya, S. K., Raina, R. S., Sharma, A., Thawani, V., & Dimari, D. (2012). Carbamazepine-induced erythema multiforme major in an epileptic patient with bipolar affective disorder. Journal of Pharmacology and Pharmacotherapeutics, 3(2), 202–204. https://doi.org/10.4103/0976-500X.95537